Skip to contentClarengateINTELLIGENCE
Companies/08272004

Typharm Developments Limited

Manufacture of basic pharmaceutical products · Norwich

ActiveUnited KingdomIncorporated 2012Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-03-31 · GBP · Company accounts

Net assets
£15,912,117
Cash
£5,844
Turnover
—
Profit / loss
—
Current assets
£16,107,226
Creditors < 1 year
£46,174
Equity
£15,912,117
Average employees
2

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

7 periods
Reported figures2025-03-31Company2024-03-31Company2023-03-312022-03-312021-03-312020-03-312013-10-09
Balance sheet
Net assets£15,912,117£11,525,776£2,057,055£1,970,447£1,906,902£1,858,014£1
Equity£15,912,117£11,525,776£2,057,055£1,970,447£1,906,902£1,858,014£1
Assets
Fixed assets———£91,070£131,070£171,070—
Intangible assets———£60,000£100,000£140,000—
Current assets£16,107,226£11,679,225£2,230,399£2,076,676£2,054,382£1,991,986—
Cash at bank£5,844£5,023,333—————
Debtors£16,101,382£6,655,892£2,230,399£2,001,288£1,985,289£1,842,745—
Stock———£75,388£69,093£149,241—
Liabilities
Creditors within one year£46,174£9,839£31,735£2,940£67,470£50,269—
Net current assets£16,061,052£11,669,386£2,198,664£2,073,736£1,986,912£1,941,717—
Assets less current liabilities£16,092,122£11,700,456£2,229,734£2,164,806£2,117,982£2,112,787—
People & pay
Average employees222222—
Source evidenceView filing View filing View filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges
Show 1 satisfied / released
All Assets · created 2015-02-09 · satisfied 2025-01-08
—
Satisfied